Journal ArticleDOI
An Efficient Synthesis of an αvβ3 Antagonist
Nobuyoshi Yasuda,Yi Hsiao,Mark S. Jensen,Nelo R. Rivera,Chunhua Yang,Kenneth M. Wells,James Yau,Michael Palucki,Lushi Tan,Peter G. Dormer,Ralph P. Volante,David L. Hughes,Paul J. Reider +12 more
Reads0
Chats0
TLDR
A practical preparation of an alpha(v)beta(3) antagonist is reported, which consists of three key components, a tetrahydronaphthyridine moiety, a beta-alanine moieties, and a central imidazolidone moiety.Abstract:
A practical preparation of an αvβ3 antagonist is reported. The antagonist consists of three key components, a tetrahydronaphthyridine moiety, a β-alanine moiety, and a central imidazolidone moiety. The tetrahydronaphthyridine component was prepared using two different methods, both of which relied on variations of the Friedlander reaction to establish the desired regiochemistry. The β-alanine component was prepared using Davies' asymmetric 1,4-addition methodology as the key stereo-defining step. The central imidazolidone portion was created from these two components using an effective three-step cyclization protocol. Thus, a highly convergent process for the drug candidate was defined.read more
Citations
More filters
Journal ArticleDOI
Large-scale applications of transition metal-catalyzed couplings for the synthesis of pharmaceuticals.
Javier Magano,Joshua R. Dunetz +1 more
Journal ArticleDOI
Mitsunobu and Related Reactions: Advances and Applications
TL;DR: This review concludes that Etherification without Cyclization and N-Alkylation should be considered as separate science, and the proposed treatment of Etherification with Cyclization as a separate science should be reconsidered.
Journal ArticleDOI
Recent Advances in the Friedländer Reaction
José Marco-Contelles,Elena Pérez-Mayoral,Abdelouahid Samadi,Maria do Carmo Carreiras,Elena Soriano +4 more
Journal ArticleDOI
Asymmetric Synthesis of Active Pharmaceutical Ingredients
Journal ArticleDOI
The conjugate addition of enantiomerically pure lithium amides as homochiral ammonia equivalents: scope, limitations and synthetic applications
TL;DR: In this paper, the scope and limitations of the conjugate addition of homochiral lithium amides to act as homochirionic ammonia equivalents for the asymmetric synthesis of a range of β-amino carboxylic acid derivatives and its widespread applications in synthesis are discussed.
References
More filters
Journal ArticleDOI
Asymmetric synthesis of R-β-amino butanoic acid and S-β-tyrosine: Homochiral lithium amide equivalents for Michael additions to α,β-unsaturated esters.
Stephen G. Davies,Osamu Ichihara +1 more
TL;DR: The addition of the lithium amide derived from R-N-(α-methylbenzyl)benzylamine to benzyl E-crotonate is highly stereoselective, giving after debenzylation and crystallisation homochiral R-β-amino butanoic acid.
Journal ArticleDOI
A mild two-step method for the hydrolysis of lactams and secondary amides
Journal ArticleDOI
Organometallic ring-opening reactions of N-acyl and N-alkoxycarbonyl lactams. Synthesis of cyclic imines
Journal ArticleDOI
The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats
M. Yamamoto,John E. Fisher,Michael A. Gentile,J.G. Seedor,Chi-Tai Leu,Sevgi B. Rodan,Gideon A. Rodan +6 more
TL;DR: Results provide in vivo evidence, at the level of bone histology, that RGD-binding integrins, probably alpha(v)beta3, play a rate-limiting role in osteoclastic bone resorption and suggest a therapeutic potential for integrin ligands in the suppression of bone loss.
Journal ArticleDOI
Highly regioselective Friedländer annulations with unmodified ketones employing novel amine catalysts: syntheses of 2-substituted quinolines, 1,8-naphthyridines, and related heterocycles.
Peter G. Dormer,Kan K. Eng,Roger N. Farr,Guy R. Humphrey,J. Christopher McWilliams,Paul J. Reider,Jess Sager,Ralph P. Volante +7 more
TL;DR: The most reactive and regioselective catalyst was the bicyclic pyrrolidine derivative, TABO (1,3,3-trimethyl-6-azabicyclo[3.2.1]octane), yielding 1,8-naphthyridines with as high as 96:4 regiOSElectivity.
Related Papers (5)
Nonpeptide alphavbeta3 antagonists. 8. In vitro and in vivo evaluation of a potent alphavbeta3 antagonist for the prevention and treatment of osteoporosis.
John H. Hutchinson,Wasyl Halczenko,Karen M. Brashear,Michael J. Breslin,Paul J. Coleman,Le T. Duong,Carmen Fernandez-Metzler,Michael A. Gentile,John E. Fisher,George D. Hartman,Joel R. Huff,Donald B. Kimmel,Chih-Tai Leu,Meissner Robert S,Kara Merkle,Rose M. Nagy,Brenda L Pennypacker,James J. Perkins,Thomayant Prueksaritanont,Gideon A. Rodan,Sandor L. Varga,Greg A Wesolowski,Amy E. Zartman,Sevgi B. Rodan,Mark E. Duggan +24 more